MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

1.53
Delayed Data
As of Apr 20
 +0.04 / +2.68%
Today’s Change
1.28
Today|||52-Week Range
6.90
-27.14%
Year-to-Date
No recent news for MabVax Therapeutics Holdings Inc.

Today’s Trading

Previous close1.49
Today’s open1.52
Day’s range1.36 - 1.68
Volume66,663
Average volume (3 months)119,461
Market cap$15.1M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+94.58%
Earnings growth (this year)--
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)-88.31%
P/E ratioNM
Price/Sales552.41
Price/Book3.99

Competitors

 Today’s
change
Today’s
% change
SSKNSTRATA Skin Sciences...-0.01-0.83%
EVFMEvofem Biosciences I...-0.15-2.34%
BSPMBiostar Pharmaceutic...-0.00-0.00%
ACERAcer Therapeutics In...-0.19-1.00%
Data as of 3:59pm ET, 04/20/2018

Financials

Last reporting dateAugust 14, 2017
EPS forecast (this quarter)-$2.07
Annual revenue (last year)$148.1K
Annual profit (last year)-$17.7M
Net profit margin-11,928.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John David Hansen
Chief Financial Officer
Gregory P. Hanson
Corporate headquarters
San Diego, California

Forecasts